TCI Wealth Advisors’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-36
Closed -$3.73K 1387
2023
Q1
$3.73K Sell
36
-30
-45% -$3.33K ﹤0.01% 1728
2022
Q4
$7.61K Buy
66
+1
+2% +$116 ﹤0.01% 1254
2022
Q3
$7K Sell
65
-1
-2% -$143 ﹤0.01% 1265
2022
Q2
$12K Buy
66
+30
+83% +$5.37K ﹤0.01% 904
2022
Q1
$6K Sell
36
-53
-60% -$9.99K ﹤0.01% 1436
2021
Q4
$19K Buy
89
+29
+48% +$5.99K ﹤0.01% 736
2021
Q3
$12K Sell
60
-15
-20% -$3.69K ﹤0.01% 984
2021
Q2
$21K Buy
75
+8
+12% +$2.17K ﹤0.01% 604
2021
Q1
$14K Buy
67
+27
+68% +$6.46K 0.01% 686
2020
Q4
$8K Buy
40
+4
+11% +$707 ﹤0.01% 714
2020
Q3
$6K Hold
36
﹤0.01% 719
2020
Q2
$5K Buy
36
+27
+300% +$2.48K ﹤0.01% 750
2020
Q1
$1K Buy
+9
New +$819 ﹤0.01% 1280
2019
Q4
Sell
-11
Closed -$1K 1631
2019
Q3
$1K Buy
11
+2
+22% +$215 ﹤0.01% 1332
2019
Q2
$1K Buy
+9
New +$1.25K ﹤0.01% 1246
2018
Q4
Sell
-10
Closed -$2K 1560
2018
Q3
$2K Buy
10
+5
+100% +$1.01K ﹤0.01% 1051
2018
Q2
$1K Buy
+5
New +$639 ﹤0.01% 1326

Other funds holding MED

TCI Wealth Advisors's MED Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Medifast (MED) in Q2 2023, closing a stake of 36 shares — an estimated $3.73K sold.

TCI Wealth Advisors first reported a position in MED in Q2 2018 and held it in 17 quarters. The position peaked at $21K in Q2 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 36 Medifast shares in Q2 2023, an estimated $3.73K.
  • TCI Wealth Advisors first reported a position in Medifast in Q2 2018 and held it in 17 quarters.
  • TCI Wealth Advisors's Medifast position peaked at $21K in Q2 2021.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.